Publications by authors named "Jason Roberts"

Claim this Profile
E
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias.
Tammy Ryan, Jason D Roberts

Heart Fail Clin· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections.
Eva Benavent, Jaime Lora-Tamayo, Marta Ulldemolins, Paula Pons-Oltra, Matthieu Gregoire, Jason A Roberts

Antimicrob Agents Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convalescent plasma in hospitalised patients with COVID-19.
Zoe McQuilten, Matthew V N O'Sullivan, Damien Purcell, Peta Edler, Niamh Meagher, Jason Roberts

Intern Med J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome.
Benjamin M Moore, Douglas Chan, Brianna Davies, Zachary W M Laksman, Jason D Roberts

Circulation· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combined effects of multiple stressors in an endangered, long-lived species: Lessons learned and ways forward.
Enrico Pirotta, Peter L Tyack, Jeffrey Adams, Michael J Asaro, Phil J Bouchet, Jason J Roberts

Ecol Appl· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefazolin pharmacokinetics during prolonged intermittent kidney replacement therapy.
Jessica H Xu, Sam Salman, David Jr Morgan, Hayoung Won, Steven C Wallis, Jason A Roberts

Anaesth Intensive Care· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early recurrence of atrial arrhythmia and healthcare utilization during the 8-week blanking period following thermal energy catheter ablation of atrial fibrillation.
Alexander P Benz, Guy Amit, William F McIntyre, Jasrita Singh, Juan G Acosta-Vélez, Jason D Roberts

Heart Rhythm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibacterial Pharmacokinetics in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO): A Systematic Review of Population Pharmacokinetic Studies.
Chanelle Ren, Frank Huang, Vesa Cheng, Jiao Xie, Jason A Roberts

Clin Pharmacokinet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification.
Krystien V Lieve, Christian van der Werf, Dania Kallas, Isabelle Denjoy, J Martijn Bos, Jason D Roberts

Eur Heart J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pharmacokinetic Analysis of Intravenous Fluconazole in Adult Patients Undergoing Mechanical Circulatory Support Device Implantation.
Kelly A Cairns, Maria Patricia Hernandez-Mitre, Trisha N Peel, Iain J Abbott, David M Kaye, Jason A Roberts

Clin Pharmacokinet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the numbers: do nomograms capture the complexity of RRT dosing? Author's reply.
Manuel Colmenero, Jason A Roberts, Jeffrey Lipman, Marta Ulldemolins

Intensive Care Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic residual drug error in the intensive care unit: A qualitative exploration of awareness, causes, and solutions.
Paul Jarrett, Fiona M Coyer, Debbie Long, Jason A Roberts, Samantha Keogh

Aust Crit Care· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of an Ex Vivo Pediatric Extracorporeal Membrane Oxygenation Circuit on Sequestration of Antimicrobials.
Michele L Cree, Mohd Hafiz Abdul-Aziz, Emma Haisz, Steven C Wallis, Hayoung Won, Jason A Roberts

Crit Care Explor· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An easy-to-use predictive score for identifying patients at risk of suboptimal linezolid exposure and candidates for therapeutic drug monitoring.
Daniel Fresán, Luisa Sorlí, Jaume Barceló-Vidal, Ana Rodrigo-Moreno, Rosana Muñoz, Jason Roberts

Int J Antimicrob Agents· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review and meta-analysis of the global epidemiology of carbapenem-resistant Escherichia coli.
Mikaela M Walker, Jason A Roberts, Yixuan Li, Fekade B Sime

Int J Antimicrob Agents· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia.
Julia Laporte-Amargos, Marta Ulldemolins, María Patricia Hernández-Mitre, Jason A Roberts, Raul Rigo-Bonnin

Antimicrob Agents Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review.
Anne Coste, Cécile Aubron, Séverine Ansart, Jason Roberts, Florent Morio

Crit Care· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic therapy for severe bacterial infections.
Jean-François Timsit, Lowell Ling, Etienne de Montmollin, Hendrik Bracht, Andrew Conway-Morris, Jason A Roberts

Intensive Care Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjects.
María Patricia Hernández-Mitre, Steven C Wallis, Jeffery S Loutit, David C Griffith, Jason A Roberts

Antimicrob Agents Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring time-to-detection of recurrent atrial fibrillation in patients with transient new-onset atrial fibrillation detected initially during hospitalization for noncardiac surgery or medical illness.
William F McIntyre, Linda S Johnson, Alexander P Benz, Maria E Vadakken, Nicole R Latendresse, Jason D Roberts

Eur J Intern Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fluconazole population pharmacokinetics study to improve target attainment in critically ill patients.
My-Luong Vuong, Omar Elkayal, Ruth Van Daele, Jan-Willem C Alffenaar, Sophie L Stocker, Jason A Roberts

Infection· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment.
Helmi Sulaiman, Muhammad Azrai Rozali, Santosh K S Adiraju, M Shahnaz Hasan, Janattul A Jamal, Jason A Roberts

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgery.
Vesa Cheng, Jessica Suna, Xin Liu, Gregory Moloney, Supreet P Marathe, Jason A Roberts

Anaesth Crit Care Pain Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Network of Antibiotic Allergy Nations (iNAAN): Protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challenge.
Elise A Mitri, Luke R Fletcher, Camille Paynter, Sara Vogrin, Fiona James, Jason A Roberts

PLoS One· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finding the optimal regimen for treatment (FORT) in people with pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trial.
Tiffany Jong, Timothy Baird, Helen Louise Barr, Scott Bell, Theophile Bigirumurame, Jason A Roberts

BMJ Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis